chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore Arm, Headache, temperature, irregular heart rate, chills, night sweats, loss of appetite, extreme fatigue, weakness, cloudy thought, swollen lymph node under left arm (size of tennis ball), labored breathing which has continued to date of this report.
Few minutes after vaccines were administered, the patient went into shock and her breathing became shallow.  I administered EpiPen and 911 was called.
reaction "exactly the same as everybody else's"; "mild flu"; Really tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (reaction "exactly the same as everybody else's"), INFLUENZA ("mild flu") and FATIGUE (Really tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (reaction "exactly the same as everybody else's"), INFLUENZA ("mild flu") and FATIGUE (Really tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION COMPLICATION (reaction "exactly the same as everybody else's"), INFLUENZA ("mild flu") and FATIGUE (Really tired) outcome was unknown.            The action taken with mRNA-1273 with the event was considered as not applicable. Concomitant information was not reported.
12 month old 10 days after varicella immunization administration redness/swelling that increased after 4 days starting on antibiotics for possible secondary infection.
Headache; Nausea; very fatigued/feeling really tired; has low energy; It is hard to work; This is a spontaneous report from a contactable consumer (Patient) or other non hcp.   A 50-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3248, Expiration date: not reported) via an unspecified route of administration, administered in Arm Left on 17Feb2021 at 10:50 (at the age of 50-years-old) as dose 2, single for covid-19 immunization. The patient medical history was not reported. Concomitant medication(s) included fluoxetine taken 40 mg, 1x/day; topiramate and bupropion taken 300 mg, 1x/day, all taken for decreased appetite, start and stop date was unknown. patient previously received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE; Lot Number: EL3248), via an unspecified route of administration on 30Jan2021 (at the age of 50-years-old) as a single dose for COVID-19 immunization. On 17Feb2021, patient experienced headache, nausea, very fatigued/feeling really tired, has low energy and It is hard to work. The nausea and headache went away. She has continued to be tired and has low energy. No additional vaccines were administered on Same Date of the Pfizer suspect. No AE(s) prior to vaccinations.The outcome of events very fatigued/feeling really tired was not recovered, outcome of event headache and nausea was recovered on an unspecified date, outcome of event has low energy and It is hard to work was unknown.  Follow-up attempts completed. No further information expected.
fine rash reported by mom 215PM 11FEB99 no itching not urticarial pruritic;feels it is viral exanthem;pt did have peanut butter cookie @school 11FEB99;mom reports rash different than prev rash;
liver enzymes were high; URI/Flu like symptoms; Flu like symptoms; Diarrhea; chills; fever; weird taste; weird smell; thrush; lesions in my mouth; persistent cough; dizziness; nausea; runny nose; extreme fatigue; upper abdominal pain; This is a spontaneous report from a contactable consumer (patient). A 47-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0186), intramuscular, administered in Arm Left on 01Jun2021 14:30 (at the age of 47-year-old) as dose 1, single for covid-19 immunisation. Medical history included Diabetes from 2001 and ongoing, POTS from almost 2 years and ongoing, Mild asthma, diabetic autonomic neuropathy, possible unknown autoimmune, Glaucoma from 5 plus years and ongoing, Gastric patient from 7 years and ongoing (Sleeve then revision to RNY 2018), Upper Respiratory thrush, mouth lesions thrush. Family medical history relevant to AE(S) included Possible unknown auto immune disorder. Known allergies included PCN, Topamax, Imitex, Vancomycin, Benzoyl peroxide. Concomitant medication(s) included azithromycin (Z-PAK) taken for Upper Respiratory thrush by oral route from 21Jun2021 to 26Jun2021; Nystatin oral wash for mouth lesions thrush by Oral route from 13Jul2021 to 19Jul2021; Nystatin tablets for mouth lesions by oral route from 30Jun2021 to 12Jul2021. Patient did not receive any other vaccine in four weeks. Other medications in two weeks were reported as yes, too many to list. Patient did not have Covid prior vaccination. Covid was tested post vaccination using: Nasal Swab method (Patient had the rapid and the regular nasal). The reported that her first symptom was fatigue which progressed to URI/Flu like symptoms. The patient experienced flu like symptoms, diarrhea, chills, fever, weird taste, weird smell, thrush, lesions in my mouth, persistent cough, dizziness, nausea, runny nose, extreme fatigue, upper abdominal pain on 02Jun2021 10:00. The patient stated that her liver enzymes were high as well. The patient underwent lab tests and procedures which included Liver magnetic resonance imaging: Abnormal on 26Jul2021, sars-cov-2 test: negative on 25Jun2021 Nasal Swab, ultrasound scan: abnormal on 26Jul2021. Adverse events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Patient was advised not to get the second dose. Patient received treatment for adverse events which included two courses of antibiotics, steroids, antivirals. The outcome of fatigue was recovering, for liver enzymes were high it was unknown, and all other events was not recovered. The Pfizer product had a causal effect to the adverse event was reported as probably.  Follow-up attempts are completed. No further information is expected.
This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (Pneumonia) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis. Concurrent medical conditions included Plaque psoriasis. On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PNEUMONIA (Pneumonia) (seriousness criterion medically significant). At the time of the report, PNEUMONIA (Pneumonia) had resolved. No concomitant medications were reported. In November 2020, the patient experienced pneumonia. On an unknown date, pneumonia got resolved. Action taken of co-suspect drug ADALIMUMAB (HUMIRA) was reported as drug discontinued. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter's causality for the event of pneumonia with HUMIRA (ADALIMUMAB) was not provided. No treatment medications were reported. Company comment: This spontaneous case concerns a 47 years old female patient, no relevant medical history, who experienced, unexpected the serious (medically significant) event of pneumonia, which occurred approximately 14 months prior to the third dose of mRNA-1273, At the time of reporting event had resolved. No further details on clinical course, treatment received lab results were reported. Patient´s concomitant medication Adalimumab remains as risk factor for infections (as pneumonia). The benefit risk relationship of mRNA-1273 is not affected by this report. Sender's Comments: This spontaneous case concerns a 47 years old female patient, no relevant medical history, who experienced, unexpected the serious (medically significant) event of pneumonia, which occurred approximately 14 months prior to the third dose of mRNA-1273, At the time of reporting event had resolved. No further details on clinical course, treatment received lab results were reported. Patient´s concomitant medication Adalimumab remains as risk factor for infections (as pneumonia). The benefit risk relationship of mRNA-1273 is not affected by this report.
First Pfizer shot was January 11, 2022, no reaction, was fine. February 1, 2022 next morning metal taste started, stayed 4 days then left but back again. Then February 4th back again on and off through February. Now since March 1st constant food taste awful and very dry mouth, also that awful taste is constant non stop now its awful. Ask neurologist, GI doctor, PC doctor, and hematology doctor, and pharmacy but no one had any answers on what to do or heard of any other patients with this so far.
Information has been received from a health professional concerning a 4 year old white male patinet who on 09APR2001 was vaccinated by subcutaneous injection in the left thigh with a first dose of varicella vaccine live. The reporter noted that on Sunday 11MAY2003 the patient, "broke out with about 70 chickenpox lesions (also reported as water blisters) on his head, lower arms, chest and groin". It was also noted the patient had a fever a week before the blisters appeared. It was noted the patient had been vaccinated at a two year check up and he had not been ill at the time of vaccination. Follow up information from the physician indicated the patient's mother was instructed via telephone conversation to use the following treatment, acetaminophen (TYLENOL), ibuprofen (MOTRIN), liquid diphenhydramine (BENADRYL), and calamine lotion. The physician reported the patient was "followed up" on 20MAY2003, and was reported as "doing better'. He was reported to have recovered 19MAY2003.
Sore achy arm the first night.  The next day, chills, fever,  nausea then that night and this morning experiencing lots of pain under arm, armpit,and breast area. Severe headache and chills and hot flashes today.
Persisting ache in triceps muscle of left arm MD thought may have been given IM but was subcut. as should be.
Information has been received from a physician concerning an unknown number of female patients with no pertinent medical history or drug allergies who were vaccinated with GARDASIL (lot # not reported). It was reported that the patients experienced injection site reactions like redness, pain, swelling and burning after getting the vaccines. At the time of reporting, the patients' outcomes were unknown. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
Pt recvd 2-1cc injects of Recombivax 29NOV90 & 29DEC90; 29MAY91 recvd Engerix-B; pt "did not develop immunity";
pt recv vax 1030AM on 5FEB97 started high shrill cry (inconsolable beginning # 330PM-lasted approx 45"-1hr;rt thigh to touch;
fatigue and headache starting 1 day after injection. Mild rash on torso 4 days post infection.
Dizziness, Headache, Chills,  Fever ( Mild),  Cough , Wheezing.
8/26 - Site soreness, fatigue in evening 8/27 - AM: fatigue, malaise, site soreness/hard/swollen                PM: gross hematuria, body aches, chills, congestion 8/28 - Body aches, site sore/hard/swollen, gross hematuria, malaise 8/29 - Body aches, site sore/hard/swollen, gross hematuria, malaise 8/30 - site soreness 8/31 - site soreness
severe itching at the injection site; rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (severe itching at the injection site) and VACCINATION SITE RASH (rash at the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (severe itching at the injection site) and VACCINATION SITE RASH (rash at the injection site). At the time of the report, VACCINATION SITE PRURITUS (severe itching at the injection site) and VACCINATION SITE RASH (rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.
I am one of the 1% to contracted COVID; I am one of the 1% to contracted COVID; This is a spontaneous report from a contactable consumer (patient) forwarded as an adverse event by the Team. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCIN), 1st dose on an unspecified date as single dose, 2nd dose on an unspecified date as single dose; via an unspecified route of administration (Batch/Lot number was not reported) for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that "I am one of the 1% to contracted COVID" on an unspecified date. The patient underwent lab tests and procedures which included COVID: contracted COVID on an unspecified date. The patient was one of the 1% to contracted COVID after being fully vaccinated with the Pfizer vaccine for over 6 weeks. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
John & Johnson shot - severe headache and flu symptoms 8 hours after vaccination and lasting many days afterward.  Chills, body aches, and major headache.
Three hrs after shot I experienced a weird feeling off and on. 2 hrs after that I was freezing to death couldn't stop shaking for 4 hrs-covered with 4 blankets. Warmed up to where I was burning up with 102.4 temp. Took 2 Tylenol and gradually subsided. Next day weak feeling and not so perky.
Shortly after receiving the covid vaccination, he began to complain of visual disturbance, nausea and vomiting.  He had dry heaves and had biohazard container.  He complained of chest tightness at 1:20 pm with BP=140/80-97% pulse ox and 74 pulse.  At 1:25 pm, he was 112/70, 97% and 66 heart .  After sitting total of 30 minutes, he left the recovery to go home and his dizziness had dissipated.
2 pts recvd Engerix-B & did not respond; (see EBU 920814);
LOSS OF CONSCIOUSNESS/PASSED OUT; DIZZY; COULD NOT WALK; SPINAL SURGERY IMMEDIATELY AFTER THE INCIDENT; LIMPRING ON RIGHT LEG, BEFORE AND AFTER THE SURGERY; RIGHT ARM NUMBED BEFORE AND AFTER THE SURGERY; This spontaneous report received from a patient concerned a 63 year old male. The patient's height, and weight were not reported. The patient's past medical history included: neck pain for 10-15 years, and concurrent conditions included: psoriatic arthritis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown, expiry: unknown) dose was not reported, administered on 13-JUL-2021 for prophylactic vaccination on right arm. The batch number was not reported and has been requested. Concomitant medications included Stelera (ustekinumab).  In JUL-2021, the patient experienced loss of consciousness, dizzy, could not walk, spinal surgery immediately after the incident, limpring on right leg, before and after the surgery, and right arm numbed before and after the surgery. On an unspecified date, the patient visited emergency room for these events. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dizzy, loss of consciousness, could not walk, spinal surgery immediately after the incident, right arm numbed before and after the surgery and limpring on right leg, before and after the surgery was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20220200405-covid-19 vaccine ad26.cov2.s- Loss of consciousness.This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event
After receiving vaccine patient sat and waited for her husband to receive same vaccine. Both patients seemed to be afterward and left the store. While on way to car patient told husband she was not feeling well. He took her to nearby emergency room. The next day patient called to let Pharmacist know about reaction. After reporting to ER, it was determined that patient may have suffered a seizure, possibly from a reaction to Shingrix Vaccine. Patient stated that the hospital kept her overnight for observation and was released the following day.
Fever, swelling in L arm and rash to abdomen.  Chills first night.  Took TSA, the bump on L arm is flattening out.  Was painful before - more sensitive than pain.  Today exam shows: L arm 2x3 cm induration, warm; scattered erythema papules abd, chest.
Rash on back, neck, and one on hand and one on eyelid. Body aches, fever, and fatigue.
Info has been received from a registered nurse concerning an adolescent PT who was vax'd w/Hep B vax recombinant. Subsequently the PT experienced weight gain and joint pain. Add'l info has been requested.
Developed pain and erythema extending from injection site to elbow on Left arm. One day after recieving injection. Treated with keflex 500mg TID X10 days
Pt received flu shot at 930a, around 1130a patient felt "woozy". Her head felt funny. She had numbness in her nose, upper lips, and ears. She took chlorpheniramine, then BENADRYL at bedtime. Still had symptoms 3 days later.
Acute migratory joint pain. In hands, hips and ribs. Started March 25 still happening.
Over the course of 3 months or so, from roughly Aug. 15 till today, I experienced declining muscle strength in my upper body and legs, and great discomfort when I try to exercise. For example, whereas I was regularly doing  15 push-ups and 5 pull-ups, I can now do only 5 or 6 push-ups and no pull-ups.
Localized erythema at site of DTaP  2 cm with firm induration managed conservatively with observation
No additional AEs; The healthcare worker reported that a patient received improperly stored vaccine.; This spontaneous report has been received from a healthcare worker referring a 4-month-old patient of unknown gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 27-AUG-2022, the patient was vaccinated with one dose of an improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, administered orally for prophylaxis, lot number W004504 with expiration date 16-JUN-2023 or lot number W002562 with expiration date 12-OCT-2023.  (Healthcare worker did not specify which actual lot number the patient received) (strength, dose, frequency and route of administration not provided) (product storage error).  The administered dose of the vaccine experienced a temperature excursion of 11.3 degrees Celsius (C) for 34 minutes; no previous temperature excursion happened. There was no adverse effect reported.
Patient admitted 11/27/2021 on Inpatient Status with weakness and shortness of breath after speaking with the Telephone Nurse Advisor.  He was tested for COVID on 11/26/2021 and the results were Positive.  He has been Vaccinated with the Moderna vaccine (2/11/21 and 3/12/21) but had not received a booster yet.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Physician). The reporter is the patient.  A 28-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course include rebound symptoms with sore throat, headache, but no fevers, as of 01Aug COVID 19 treatment of paxlovid and treatment start date was 24Jul2022 and treatment stop date was 04Aug2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the available information and possible temporal association the causal relationship between the reported event and suspect cannot be excluded.The case will be reviewed further with FU information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
Improperly administered (too high). Resulted in R shoulder required treatment and physical therapy due to limited ROM.
Side effects include: Body aches,persistent headache, mild chills, general weakness and fatigue, and extremely sore arm at the injection site and swelling of the lymph node in the 'armpit' of the injection side.
Poison ivy; This is a spontaneous report received from a contactable consumer for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received BNT162B2 (BNT162B2), administration date 14Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DERMATITIS CONTACT (non-serious), outcome "unknown", described as "Poison ivy". Therapeutic measures were taken as a result of dermatitis contact.  Additional Information: The patient got poison ivy and is taking prednisone. The patient was scheduled already for her second shot and wanted to know if it is okay to get it.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Second dose COVID vaccine was given at 9:17 am few moments later around 9:22 am  patient fainted. Immediately patient was laid down on her back with feet elevated and vitals were taken. DO examined patient. Orange juice and chocolate was given to patient. Per DR. patients vitals were normal. Patient waited 30 min post injection.
Pain in the area of shot and up and down the arm, low-grade fever (99.5 F) pain in arm started night of the shot. Fever noticed around 3:00 pm, Aug 1.